BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 30115472)

  • 21. Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbances.
    Carlsson S; Rydén A; Rudberg I; Bove M; Bergquist H; Finizia C
    Dysphagia; 2012 Sep; 27(3):361-9. PubMed ID: 22105944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Ursino S; Calistri E; De Felice F; Bonomo P; Desideri I; Franco P; Arcadipane F; Colosimo C; Mazzola R; Maddalo M; Gonnelli A; Malfatti G; Morganti R; Musio D; Paiar F
    Dysphagia; 2023 Feb; 38(1):159-170. PubMed ID: 35587295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.
    Holländer-Mieritz C; Johansen J; Johansen C; Vogelius IR; Kristensen CA; Pappot H
    Acta Oncol; 2019 May; 58(5):603-609. PubMed ID: 30698098
    [No Abstract]   [Full Text] [Related]  

  • 24. Translation and validation of the MD Anderson Dysphagia Inventory (MDADI) for Spanish-speaking patients.
    Montes-Jovellar L; Carrillo A; Muriel A; Barbera R; Sanchez F; Cobeta I
    Head Neck; 2019 Jan; 41(1):122-129. PubMed ID: 30549341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head and Neck Cancer: A Study on the Complex Relationship between QoL and Swallowing Function.
    Strüder D; Ebert J; Kalle F; Schraven SP; Eichhorst L; Mlynski R; Großmann W
    Curr Oncol; 2023 Dec; 30(12):10336-10350. PubMed ID: 38132387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can the Risk of Dysphagia in Head and Neck Radiation Therapy Be Predicted by an Automated Transit Fluence Monitoring Process During Treatment? A First Comparative Study of Patient Reported Quality of Life and the Fluence-Based Decision Support Metric.
    Lim SB; Lee N; Zakeri K; Greer P; Fuangrod T; Coffman F; Cerviño L; Lovelock DM
    Technol Cancer Res Treat; 2021; 20():15330338211027906. PubMed ID: 34190006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
    Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
    Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment Dysphagia Inventory and videofluorographic swallowing study as prognostic indicators of early survival outcomes in head and neck cancer.
    Yang CJ; Roh JL; Choi KH; Kim MJ; Choi SH; Nam SY; Kim SY
    Cancer; 2015 May; 121(10):1588-98. PubMed ID: 25639759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
    Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life in oncological patients with oropharyngeal dysphagia: validity and reliability of the Dutch version of the MD Anderson Dysphagia Inventory and the Deglutition Handicap Index.
    Speyer R; Heijnen BJ; Baijens LW; Vrijenhoef FH; Otters EF; Roodenburg N; Bogaardt HC
    Dysphagia; 2011 Dec; 26(4):407-14. PubMed ID: 21279522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptation and validation of the Italian MD Anderson Dysphagia Inventory (MDADI).
    Schindler A; Borghi E; Tiddia C; Ginocchio D; Felisati G; Ottaviani F
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(2):97-100. PubMed ID: 18767327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
    Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
    BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between swallowing-related quality of life and videofluoroscopy after head and neck cancer treatment.
    Andrade MS; Gonçalves AN; Guedes RL; Barcelos CB; Slobodticov LD; Lopes SA; Francisco AL; Angelis EC
    Codas; 2017 Mar; 29(1):e20150175. PubMed ID: 28300950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Swallowing outcome measures in head and neck cancer--How do they compare?
    Pedersen A; Wilson J; McColl E; Carding P; Patterson J
    Oral Oncol; 2016 Jan; 52():104-8. PubMed ID: 26564310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
    Goepfert RP; Lewin JS; Barrow MP; Gunn GB; Fuller CD; Beadle BM; Garden AS; Rosenthal DI; Kies MS; Papadimitrakopoulou V; Lai SY; Gross ND; Schwartz DL; Hutcheson KA
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):700-708. PubMed ID: 27485284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
    Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
    Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Head and Neck Cancer Treatment on Survivors' Mealtime Experience.
    Chan KMK; Chan HKW; Siu JYL; Pu D; Nund RL; Ward EC
    Laryngoscope; 2019 Jul; 129(7):1572-1578. PubMed ID: 30284283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity and Reliability of an Arabic Version of MD Anderson Dysphagia Inventory (MDADI).
    Alsubaie HM; Sayed SI; Alsini AY; Alkaff HH; Margalani OA; Abu-Zaid A; Abu-Suliman OA; Alherabi AZ; Alghamdi SA; Saleh E; Alessa MA; Abdelmonim SK
    Dysphagia; 2022 Aug; 37(4):946-953. PubMed ID: 34427776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between depressive symptoms, quality of life, and swallowing function in head and neck cancer patients 1 year after definitive therapy.
    Lin BM; Starmer HM; Gourin CG
    Laryngoscope; 2012 Jul; 122(7):1518-25. PubMed ID: 22467530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.